KRISTY HAMMERSCHMIDT: Open Payments
NPI 1942679675 · LIBERTY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,743 in 51 payments from 18 companies in 2025. Trend: 2023 $47 · 2024 $1,241 · 2025 $1,743
Food & beverage: $1,743
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 7 | $458 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $222 |
| QOL Medical, LLC | 4 | $183 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $145 |
| ABBVIE INC. | 8 | $142 |
| Lilly USA, LLC | 5 | $141 |
| Regeneron Healthcare Solutions, Inc. | 1 | $113 |
| Ardelyx, Inc. | 3 | $76 |
| Phathom Pharmaceuticals, Inc. | 3 | $53 |
| Intercept Pharmaceuticals, Inc. | 2 | $45 |
Products named: TREMFYA, ENTYVIO, Sucraid, XIFAXAN, OMVOH, RINVOQ, IBSRELA, VOQUEZNA.
Industry payments across MO — which companies pay providers there.
